Insider · CIK 0001380762

Dorsey Brian

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001380762

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Operating Officer	AAward	+240K sh	—	—	240,000
2025-11-13	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+21.8K sh	$0.64	+$14K	32,617
2025-11-13	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−21.8K sh	$8.71	−$190K	10,789
2025-11-13	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−21.8K sh	—	—	0
2025-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Operating Officer	AAward	+262K sh	—	—	261,900
2024-12-12	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$0.64	+$16K	31,024
2024-12-12	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−25K sh	$12.30	−$307K	6,024
2024-12-12	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	21,828
2024-12-11	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+15K sh	$0.64	+$9,600	21,024
2024-12-11	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−15K sh	$12.43	−$186K	6,024
2024-12-11	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−15K sh	—	—	46,828
2024-08-20	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+50K sh	$0.64	+$32K	56,024
2024-08-20	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−50K sh	$15.00	−$750K	6,024
2024-08-20	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−50K sh	—	—	61,828
2024-08-13	SPRYARS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+30K sh	$0.64	+$19.2K	36,024
2024-08-13	SPRYARS Pharmaceuticals, Inc.S Sale	Chief Operating Officer	SSale	−30K sh	$13.00	−$390K	6,024
2024-08-13	SPRYARS Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−30K sh	—	—	111,828
2024-01-02	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Operating Officer	AAward	+350K sh	—	—	350,000
2023-01-03	SPRYARS Pharmaceuticals, Inc. · Stock option (right to buy)A Award	Chief Operating Officer	AAward	+145K sh	—	—	145,000
2018-08-30	SEELOS THERAPEUTICS, INC.M Exercise/Conversion	Former SVP, Chief Dev Officer	MExercise/Conversion	+81.8K sh	—	—	159,116
2018-08-30	SEELOS THERAPEUTICS, INC.F Tax Payment	Former SVP, Chief Dev Officer	FTax Payment	−43.2K sh	$0.33	−$14.3K	115,891
2018-01-03	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Former SVP, Chief Dev Officer	AAward	+60K sh	—	—	60,000
2018-01-01	SEELOS THERAPEUTICS, INC.F Tax Payment	Former SVP, Chief Dev Officer	FTax Payment	−5,485 sh	$1.84	−$10.1K	159,116
2017-09-05	SEELOS THERAPEUTICS, INC.F Tax Payment	Former SVP, Chief Dev Officer	FTax Payment	−14.1K sh	$1.56	−$22K	164,601
2017-06-01	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	+75K sh	—	—	178,694
2017-02-15	SEELOS THERAPEUTICS, INC.F Tax Payment	Former SVP, Chief Dev Officer	FTax Payment	−1,495 sh	$2.78	−$4,156.1	103,694
2017-01-05	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	+75K sh	—	—	105,189
2016-05-20	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	+250K sh	—	—	301,891
2016-04-25	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	+250K sh	—	—	301,891
2016-04-25	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	0 sh	—	—	51,891
2016-03-15	SEELOS THERAPEUTICS, INC.A Award	Former SVP, Chief Dev Officer	AAward	+41.9K sh	—	—	51,891
2016-03-15	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Former SVP, Chief Dev Officer	AAward	+200K sh	—	—	200,000
2015-01-29	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Former SVP, Chief Dev Officer	AAward	+50K sh	—	—	50,000
2014-12-29	SEELOS THERAPEUTICS, INC.P Purchase	Former SVP, Chief Dev Officer	PPurchase	+10K sh	$1.05	+$10.5K	10,000
2014-12-01	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Former SVP, Chief Dev Officer	AAward	+300K sh	—	—	300,000
2014-10-10	PERNIX THERAPEUTICS HOLDINGS, INC.A Award	SVP Research	AAward	+33.3K sh	—	—	62,426
2014-10-10	PERNIX THERAPEUTICS HOLDINGS, INC.A Award	SVP Research	AAward	+50K sh	—	—	87,426
2013-04-19	PERNIX THERAPEUTICS HOLDINGS, INC.A Award	SVP Research	AAward	+50K sh	—	—	63,538
2013-04-19	PERNIX THERAPEUTICS HOLDINGS, INC.A Award	SVP Research	AAward	+47.7K sh	—	—	111,192
2013-03-06	Pernix Sleep, Inc.D Disposition to Issuer	SVP, Technical Operations	DDisposition to Issuer	−28.3K sh	—	—	0
2012-12-31	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+1,494 sh	—	—	52,264
2012-11-16	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+30K sh	—	—	50,770
2012-09-30	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+15.7K sh	—	—	166,160
2012-07-02	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+16K sh	—	—	150,444
2012-01-03	Pernix Sleep, Inc.S Sale	SVP, Technical Operations	SSale	−9,000 sh	$0.48	−$4,289.4	134,452
2011-03-07	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+30K sh	—	—	73,452
2011-03-07	Pernix Sleep, Inc.A Award	SVP, Technical Operations	AAward	+50K sh	—	—	123,452
2011-03-07	Pernix Sleep, Inc.Stock option (right to buy)A Award	SVP, Technical Operations	AAward	+100K sh	—	—	100,000
2010-12-01	Pernix Sleep, Inc.S Sale	SVP, Technical Operations	SSale	−8,468 sh	$2.68	−$22.7K	43,452
2010-09-01	Pernix Sleep, Inc.M Exercise/Conversion	SVP, Technical Operations	MExercise/Conversion	+71 sh	$1.23	+$87.33	51,991

Recent filings

Accepted (ET)
Jan 54
Dorsey Brian0001380762-26-000002
SEC(opens sec.gov)
Nov 144
Dorsey Brian0001380762-25-000005
SEC(opens sec.gov)
Jan 34
Dorsey Brian0001415889-25-000462
SEC(opens sec.gov)
Dec 134
Dorsey Brian0001415889-24-029376
SEC(opens sec.gov)
Aug 214
Dorsey Brian0001415889-24-021886
SEC(opens sec.gov)
Aug 154
Dorsey Brian0001415889-24-021364
SEC(opens sec.gov)
Jan 44
Dorsey Brian0001209191-24-000810
SEC(opens sec.gov)
Jan 54
Dorsey Brian0001209191-23-001926
SEC(opens sec.gov)
Sep 44
Dorsey Brian0001017491-18-000083
SEC(opens sec.gov)

Companies

Address

C/O SOMAXON PHARMACEUTICALS, INC. 3830 VALLEY CENTRE DRIVE, SUITE 705-461

SAN DIEGO, CA, 92130